THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,440,000 | -8.6% | 1,500,000 | 0.0% | 0.11% | +31.0% |
| Q4 2019 | $1,575,000 | +13.1% | 1,500,000 | 0.0% | 0.09% | -2.2% |
| Q3 2019 | $1,392,000 | +6.8% | 1,500,000 | 0.0% | 0.09% | +18.7% |
| Q2 2019 | $1,303,000 | -46.6% | 1,500,000 | -37.5% | 0.08% | -38.0% |
| Q1 2018 | $2,438,000 | -58.7% | 2,400,000 | -55.6% | 0.12% | -58.3% |
| Q4 2017 | $5,901,000 | +65.9% | 5,400,000 | +86.2% | 0.29% | +66.7% |
| Q3 2017 | $3,556,000 | -81.9% | 2,900,000 | -80.0% | 0.17% | -81.7% |
| Q2 2017 | $19,598,000 | +10.4% | 14,500,000 | +3.6% | 0.95% | -10.5% |
| Q1 2017 | $17,746,000 | +286.3% | 14,000,000 | +250.0% | 1.06% | +323.5% |
| Q4 2016 | $4,594,000 | – | 4,000,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
| DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
| ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
| Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
| LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
| Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
| Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |